Skip to main content

Advertisement

SpringerLink
Log in

Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Resveratrol (Res) is a natural compound with anti-cancer effects. The goal of this study is to evaluate the suppression of Res in melanoma and investigate its relationship with miRNAs during this process. The in vitro and in vivo anti-cancer abilities of Res were evaluated using cellular assays and animal model. Two melanoma cell lines (A375 and MV3) were used for both in vitro assay and in vivo experiments. qRT-PCR and Western blot were used to detect the changes in gene expressions and protein levels. Dual-luciferase reporter assay and bioinformatic tools were used to further confirm the protein binding and activation of targeted genes. In vitro experiments showed Res significantly decreased the expression of miR-221, an oncogenic microRNA, which was confirmed by the overexpression of miR-221 with or without Res treatment. Mechanistically, we showed that the inhibition of miR-221 by Res was achieved by regulating NF-κB (RELA) activity. In the meantime, we also identified that TFG, a tumor suppressor gene, was a target of miR-221. Finally, using in vivo melanoma model, we confirmed the tumor suppressive effects of Res and our in vitro regulatory network. Res displayed a significant anti-tumor effect on melanoma cells both in vitro and in vivo. The cellular mechanism under this effect involves miRNA regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Babapoor S, Wu R, Kozubek J, Auidi D, Grant-Kels JM, Dadras SS (2017) Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing. Lab Investig. doi:10.1038/labinvest.2017.5

    PubMed  Google Scholar 

  2. Basseres DS, Ebbs A, Levantini E, Baldwin AS (2010) Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res 70:3537–3546. doi:10.1158/0008-5472.CAN-09-4290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Carter LG, D’Orazio JA, Pearson KJ (2014) Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 21:R209–R225. doi:10.1530/ERC-13-0171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Dutton-Regester K, Aoude LG, Nancarrow DJ, Stark MS, O’Connor L, Lanagan C, Pupo GM, Tembe V, Carter CD, O’Rourke M, Scolyer RA, Mann GJ, Schmidt CW, Herington A, Hayward NK (2012) Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene. Genes Chromosomes Cancer 51:452–461. doi:10.1002/gcc.21932

    Article  CAS  PubMed  Google Scholar 

  5. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Care A (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68:2745–2754. doi:10.1158/0008-5472.CAN-07-2538

    Article  CAS  PubMed  Google Scholar 

  6. Gallagher SJ, Mijatov B, Gunatilake D, Gowrishankar K, Tiffen J, James W, Jin L, Pupo G, Cullinane C, McArthur GA, Tummino PJ, Rizos H, Hersey P (2014) Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151. Pigment Cell Melanoma Res 27:1126–1137. doi:10.1111/pcmr.12282

    Article  CAS  PubMed  Google Scholar 

  7. Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G (2012) miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med 12:27–33

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Giles KM, Brown RA, Ganda C, Podgorny MJ, Candy PA, Wintle LC, Richardson KL, Kalinowski FC, Stuart LM, Epis MR, Haass NK, Herlyn M, Leedman PJ (2016) microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-kappaB. Oncotarget 7:31663–31680. doi:10.18632/oncotarget.9421

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509–524. doi:10.1038/nrm3838

    Article  CAS  PubMed  Google Scholar 

  10. Haass NK, Sproesser K, Nguyen TK, Contractor R, Medina CA, Nathanson KL, Herlyn M, Smalley KS (2008) The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel. Clin Cancer Res 14:230–239. doi:10.1158/1078-0432.CCR-07-1440

    Article  CAS  PubMed  Google Scholar 

  11. Hua F, Shang S, Hu ZW (2017) Seeking new anti-cancer agents from autophagy-regulating natural products. J Asian Nat Prod Res 19:305–313. doi:10.1080/10286020.2017.1304385

    Article  CAS  PubMed  Google Scholar 

  12. Irvine M, Philipsz S, Frausto M, Mijatov B, Gallagher SJ, Fung C, Becker TM, Kefford RF, Rizos H (2010) Amino terminal hydrophobic import signals target the p14(ARF) tumor suppressor to the mitochondria. Cell Cycle 9:829–839. doi:10.4161/cc.9.4.10785

    Article  CAS  PubMed  Google Scholar 

  13. Jiang H, Shang X, Wu H, Gautam SC, Al-Holou S, Li C, Kuo J, Zhang L, Chopp M (2009) Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol 8:25–33

    PubMed  PubMed Central  Google Scholar 

  14. Junco JJ, Mancha-Ramirez A, Malik G, Wei SJ, Kim DJ, Liang H, Slaga TJ (2015) Ursolic acid and resveratrol synergize with chloroquine to reduce melanoma cell viability. Melanoma Res 25:103–112. doi:10.1097/CMR.0000000000000137

    Article  CAS  PubMed  Google Scholar 

  15. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM et al (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833–839

    Article  CAS  PubMed  Google Scholar 

  16. Leibowitz-Amit R, Sidi Y, Avni D (2012) Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma. Pigment Cell Melanoma Res 25:740–757. doi:10.1111/pcmr.12018

    Article  CAS  PubMed  Google Scholar 

  17. Lelli D, Pedone C, Majeed M, Sahebkar A (2017) Curcumin and lung cancer: the role of microRNAs. Curr Pharm Des 23:1–5

    Article  Google Scholar 

  18. Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482:347–355. doi:10.1038/nature10888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Luke JJ, Flaherty KT, Ribas A, Long GV (2017) Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 14:463–482. doi:10.1038/nrclinonc.2017.43

    Article  CAS  PubMed  Google Scholar 

  20. Luo C, Shen J (2017) Research progress in advanced melanoma. Cancer Lett. doi:10.1016/j.canlet.2017.03.037

    Google Scholar 

  21. Mattia G, Errico MC, Felicetti F, Petrini M, Bottero L, Tomasello L, Romania P, Boe A, Segnalini P, Di Virgilio A, Colombo MP, Care A (2011) Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma. Pigment Cell Melanoma Res 24:953–965. doi:10.1111/j.1755-148X.2011.00881.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. McCourt C, Dolan O, Gormley G (2014) Malignant melanoma: a pictorial review. Ulster Med J 83:103–110

    PubMed  PubMed Central  Google Scholar 

  23. Miranda C, Roccato E, Raho G, Pagliardini S, Pierotti MA, Greco A (2006) The TFG protein, involved in oncogenic rearrangements, interacts with TANK and NEMO, two proteins involved in the NF-kappaB pathway. J Cell Physiol 208:154–160. doi:10.1002/jcp.20644

    Article  CAS  PubMed  Google Scholar 

  24. Mobley AK, Braeuer RR, Kamiya T, Shoshan E, Bar-Eli M (2012) Driving transcriptional regulators in melanoma metastasis. Cancer Metastasis Rev 31:621–632. doi:10.1007/s10555-012-9358-8

    Article  CAS  PubMed  Google Scholar 

  25. Nivelle L, Hubert J, Courot E, Jeandet P, Aziz A, Nuzillard JM, Renault JH, Clement C, Martiny L, Delmas D, Tarpin M (2017) Anti-cancer activity of resveratrol and derivatives produced by grapevine cell suspensions in a 14 L stirred bioreactor. Molecules. doi:10.3390/molecules22030474

    PubMed  Google Scholar 

  26. Panday A, Inda ME, Bagam P, Sahoo MK, Osorio D, Batra S (2016) Transcription factor NF-kappaB: an update on intervention strategies. Arch Immunol Ther Exp (Warsz) 64:463–483. doi:10.1007/s00005-016-0405-y

    Article  CAS  Google Scholar 

  27. Quintavalle C, Garofalo M, Zanca C, Romano G, Iaboni M, del Basso De Caro M, Martinez-Montero JC, Incoronato M, Nuovo G, Croce CM, Condorelli G (2012) miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPmu. Oncogene 31:858–868. doi:10.1038/onc.2011.280

    Article  CAS  PubMed  Google Scholar 

  28. Ren Z, Wang L, Cui J, Huoc Z, Xue J, Cui H, Mao Q, Yang R (2013) Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities. Pharmazie 68:689–694

    CAS  PubMed  Google Scholar 

  29. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241. doi:10.3322/caac.21149

    Article  PubMed  Google Scholar 

  30. Singh SK, Banerjee S, Acosta EP, Lillard JW, Singh R (2017) Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget. doi:10.18632/oncotarget.15303

    Google Scholar 

  31. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M (2005) Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 166:1541–1554. doi:10.1016/S0002-9440(10)62370-X

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Smalley KS, Contractor R, Haass NK, Lee JT, Nathanson KL, Medina CA, Flaherty KT, Herlyn M (2007) Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer 96:445–449. doi:10.1038/sj.bjc.6603596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Thiel G, Rossler OG (2017) Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol Res 117:166–176. doi:10.1016/j.phrs.2016.12.029

    Article  CAS  PubMed  Google Scholar 

  34. Weber CE, Luo C, Hotz-Wagenblatt A, Gardyan A, Kordass T, Holland-Letz T, Osen W, Eichmuller SB (2016) miR-339-3p is a tumor suppressor in melanoma. Cancer Res 76:3562–3571. doi:10.1158/0008-5472.CAN-15-2932

    Article  CAS  PubMed  Google Scholar 

  35. Zehavi L, Schayek H, Jacob-Hirsch J, Sidi Y, Leibowitz-Amit R, Avni D (2015) MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma. Mol Cancer 14:68. doi:10.1186/s12943-015-0338-9

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Fangfang Wu and Liying Cui contributed equally to this work.

Authors and Affiliations

  1. Department of Traditional Chinese Medicine, Daqing Oilfield General Hospital, Daqing, China

    Fangfang Wu & Liying Cui

Authors
  1. Fangfang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liying Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fangfang Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Informed consent

Not applicable.

Funding

None.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 351 kb)

Supplementary material 2 (PDF 152 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, F., Cui, L. Resveratrol suppresses melanoma by inhibiting NF-κB/miR-221 and inducing TFG expression. Arch Dermatol Res 309, 823–831 (2017). https://doi.org/10.1007/s00403-017-1784-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-017-1784-6

Keywords

Search

Navigation